Cancer
A recent study by researchers from the First Affiliated Hospital of Nanjing Medical University has highlighted the importance of noninvasive imaging technologies in the early diagnosis and monitoring of cancer therapy-related cardiovascular toxicity (CTR-CVT) in tumor patients. According to the research, cardiovascular damage caused by cancer treatment has become a
Cancer
OS Therapies Inc. (NYSE-A: OSTX) is making significant progress in the fight against rare cancers, particularly osteosarcoma, with its lead candidate, OST-HER2, demonstrating statistically significant survival benefits in patients with recurrent fully resected lung metastatic osteosarcoma. The company's immunotherapy, designed to activate the immune system against HER2-expressing cancer
Cancer
Researchers at the Poznan University of Technology have made a breakthrough discovery in the field of cancer treatment, finding that bismuth selenide (BiSe) nanoparticles can be effective in targeting and killing cancer cells, with the potential to be developed into a new therapy for cancer treatment. According to the study,
Antineoplastic agents
A recent study has uncovered the pivotal role of Netrin-1, a secreted laminin-related protein, in guiding axonal growth during nervous system development, as well as its involvement in cancer progression and metastasis. The research highlights the importance of understanding the signaling pathways through which Netrin-1 operates in cancer, with the
Cancer
Cancer therapy has advanced significantly in recent years, with researchers identifying new targets for treatment. A recent study from Yale University has highlighted the importance of targeting Polo-like kinase 4 (PLK4), a serine-threonine kinase involved in centrosome duplication. The study, published in Cancer and Metastasis Reviews, discusses the role of
Cancer
A recent research study has shed new light on the multifaceted role of glutathione (GSH) in cancer biology and therapeutic interventions. According to the study, GSH plays an essential role in maintaining redox balance, mitigating oxidative stress, and preserving cellular homeostasis. Furthermore, GSH serves as a critical regulator of ferroptosis,
Cancer
Cancer treatment has just taken a significant turn with the recent patent approval of a novel method that combines bacteria and prebiotics to treat colon cancer and melanoma. The invention, patented by researchers Ashkenazi, Shiri, Bradley, Linda, Li, Yan, Peterson, Scott, Ronai, Ze'ev, and Tinoco, Roberto, from the
Cancer
Research conducted by the Institute for Biomedical Engineering has found that low-intensity pulsed ultrasound (LIPUS) significantly enhances the cellular uptake of drug-loaded gold nanoparticles (AuNPs) in cancer cells. The study used cell experiments, finite element simulations, and dark-field/hyperspectral cell imaging to demonstrate the efficacy of LIPUS in facilitating the
Antineoplastic agents
A recent study published in The Lancet Global Health has revealed alarming statistics about cancer medication defects in sub-Saharan Africa. Researchers from the University of Notre Dame collected dosage information from a dozen hospitals and 25 pharmacies across Ethiopia, Kenya, Malawi, and Cameroon, testing 251 cancer drugs. The study found
Cancer
Researchers in the Department of Radiation Oncology have made significant strides in the development of targeted nanoparticle-based therapies for treating nasopharyngeal carcinoma (NPC), a major clinical challenge characterized by high resistance to conventional therapies such as chemotherapy and radiotherapy. These nanoparticle-based technologies have emerged as promising tools to enhance the
Cancer
Researchers at the Shanghai University of Traditional Chinese Medicine have made a significant advancement in cancer therapy by developing artificial NK-EVs, which demonstrate superior scalability and bioactivity compared to natural EVs. According to the study, these artificial EVs can induce 70% cytotoxicity in lung cancer cells, trigger apoptosis, and restore
Cancer
Research presented from Memorial Sloan-Kettering Cancer Center highlights the potential association between the use of dupilumab, a monoclonal antibody inhibiting interleukin-4 receptor alpha (IL-4Ra) and interleukin-13 receptor (IL-13R), and the development of cutaneous T-cell lymphoma (CTCL) in patients with atopic dermatitis (AD). The study's authors emphasize that while
